NovoCure Limited
NVCR
$15.23
$0.030.20%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 77.99% | -190.37% | 34.27% | 7.15% | -16.96% |
| Total Depreciation and Amortization | 4.44% | 52.80% | -26.32% | 6.36% | 3.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -75.10% | 340.60% | -43.91% | -9.37% | 19.95% |
| Change in Net Operating Assets | 153.46% | 48.53% | -152.06% | 542.26% | 75.87% |
| Cash from Operations | 160.16% | 24.92% | -187.51% | 229.10% | 55.32% |
| Capital Expenditure | -34.24% | -5.23% | 13.42% | -3.08% | 48.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -95.83% | -96.22% | 342.62% | 85.89% | 901.98% |
| Cash from Investing | -182.33% | -97.70% | 370.81% | 98.51% | 656.03% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,066.15% | -75.58% | 196.84% | -77.46% | -54.51% |
| Repurchase of Common Stock | -- | -280.82% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,839.76% | 99.97% | -656.62% | 4,111.02% | -54.51% |
| Foreign Exchange rate Adjustments | 93.85% | -71.05% | -245.45% | -108.30% | 16.74% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 203.76% | 97.49% | -225.32% | 747.96% | 161.92% |